A trailblazer in the world of pharmaceutical and chemical analysis, Russell Kinghorn is the founder and managing director of Pharmalytics, Australia’s most advanced medicinal cannabis testing laboratory.

Russell is also the CEO of the Australian Cannabis Group. Under Russell's leadership, the Australian Cannabis Group has expanded its global footprint with the development of a brand new, multimillion dollar, state-of-the-art GMP manufacturing and testing facility in Bangkok, serving both the domestic and international markets.

The new facility will also be home to Pharmalytics Thailand, the Asian branch of Russell's premier GMP-certified analytical laboratory.